2025年黑色素瘤中国临床肿瘤学会和美国国家综合癌症网络指南更新解读OA

The Chinese Society of Clinical Oncology(CSCO)is an authoritative academic organization in the field of oncology in China,dedicated to standardizing cancer diagnosis and treatment,and promoting the innovation of oncology research and clinical practice with Chinese characteristics.CSCO melanoma guidelines are the first to formulate diagnosis and treatment plans based on different subtypes such as cutaneous,acral,mucosal,and uveal melanoma in the world.Currently,CSCO guidelines have been updated to the 2025 version.The National Comprehensive Cancer Network(NCCN)is a non-profit alliance consisting of 32 world-renowned cancer centers,which con-tinuously updates clinical practice guidelines for various malignant tumors every year.NCCN guidelines are not only the gold standard for clinical decision-making in the field of oncology in the United States,but also one of the most widely used clinical practice guidelines for oncology globally.Currently,NCCN clinical practice guidelines in oncology for cutaneous melanoma have been updated to version 2.2025.This article will interpret the updated contents of the above-mentioned new versions of CSCO and NCCN melanoma guidelines.